Top Job | 18/06/2024 | Fulltime | Oxford | ImmunocoreImmunocore (NASDAQ IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transformative medicines which address unmet patient needs in oncology, infectious diseases and autoimmune disease. Our leaders in R&D
Save for later